Genotoxic Exposure: Novel Cause of Selection for a Functional ΔN-p53 Isoform
Overview
Authors
Affiliations
The p53 gene is frequently mutated in cancers and it is vital for cell cycle control, homeostasis and carcinogenesis. We describe a novel p53 mutational spectrum, different to those generally observed in human and murine tumors. Our study shows a high prevalence of nonsense mutations in the p53 N terminus of 2-acetylaminofluorene (2-AAF)-induced urinary bladder tumors. These nonsense mutations forced downstream translation initiation at codon 41 of Trp53, resulting in the aberrant expression of the p53 isoform ΔN-p53 (or p44). We propose a novel mechanism for the origination and the selection for this isoform. We show that chemical exposure can act as a novel cause of selection for this truncated protein. In addition, our data suggest that the occurrence of ΔN-p53 accounts, at least in mice, for a cancer phenotype. We also show that gene expression profiles of embryonic stem (ES) cells carrying the ΔN-p53 isoform in a p53-null background are divergent from p53 knockout ES cells, and therefore postulate that ΔN-p53 itself has functional transcriptional properties.
Levandowski C, Jones T, Gruca M, Ramamoorthy S, Dowell R, Taatjes D PLoS Biol. 2021; 19(8):e3001364.
PMID: 34351910 PMC: 8370613. DOI: 10.1371/journal.pbio.3001364.
Alternative Mechanisms of p53 Action During the Unfolded Protein Response.
Fusee L, Marin M, Fahraeus R, Lopez I Cancers (Basel). 2020; 12(2).
PMID: 32050651 PMC: 7072472. DOI: 10.3390/cancers12020401.
Nonsense mutation-dependent reinitiation of translation in mammalian cells.
Cohen S, Kramarski L, Levi S, Deshe N, Ben David O, Arbely E Nucleic Acids Res. 2019; 47(12):6330-6338.
PMID: 31045216 PMC: 6614817. DOI: 10.1093/nar/gkz319.
p53 as an intervention target for cancer and aging.
Hasty P, Christy B Pathobiol Aging Age Relat Dis. 2013; 3.
PMID: 24124625 PMC: 3794078. DOI: 10.3402/pba.v3i0.22702.
Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.
Koch A, Hatina J, Rieder H, Seifert H, Huckenbeck W, Jankowiak F Cell Oncol (Dordr). 2012; 35(4):243-57.
PMID: 22669776 DOI: 10.1007/s13402-012-0082-8.